Effect of low level laser therapy on bronchial hyper-responsiveness
- PMID: 19005736
- DOI: 10.1007/s10103-008-0612-9
Effect of low level laser therapy on bronchial hyper-responsiveness
Abstract
The objective of this study was to investigate whether low level laser therapy (LLLT) could reduce bronchial hyper-responsiveness (BHR) induced by tumour necrosis factor-alpha (TNF-alpha) modulating the metabolism of inositol phosphate (IP) in bronchial smooth muscle cells (BSMCs). The study was on 28 Wistar rats, randomly divided into four groups. Irradiation (1.3 J/cm(2)) was administered 5 min and 4 h after bronchial smooth muscle (BSM) had been suspended in TNF-alpha baths, and the contractile response-induced calcium ion (Ca(2+)) sensitization was measured. The BSMCs were isolated, and the IP accumulation was measured before and after TNF-alpha immersion in the groups that had been irradiated or not irradiated. BSM segments significantly increased contraction 24 h after TNF-alpha immersion when exposed to carbachol (CCh) as Ca(2+), but it was significantly reduced by 64% and 30%, respectively, after laser treatment. The increase in IP accumulation induced by CCh after TNF-alpha immersion was reduced in the BSMCs by LLLT. The dose of 2.6 J/cm(2) reduced BHR and IP accumulation in the rats' inflammatory BSMCs.
Similar articles
-
Low-level laser therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi smooth muscle exposed to tumor necrosis factor-alpha.Lasers Med Sci. 2010 Sep;25(5):661-8. doi: 10.1007/s10103-010-0766-0. Lasers Med Sci. 2010. PMID: 20393772
-
Low level laser therapy (LLLT): attenuation of cholinergic hyperreactivity, beta(2)-adrenergic hyporesponsiveness and TNF-alpha mRNA expression in rat bronchi segments in E. coli lipopolysaccharide-induced airway inflammation by a NF-kappaB dependent mechanism.Lasers Surg Med. 2009 Jan;41(1):68-74. doi: 10.1002/lsm.20735. Lasers Surg Med. 2009. PMID: 19143014
-
Type 1 inositol 1,4,5-trisphosphate receptors mediate UTP-induced cation currents, Ca2+ signals, and vasoconstriction in cerebral arteries.Am J Physiol Cell Physiol. 2008 Nov;295(5):C1376-84. doi: 10.1152/ajpcell.00362.2008. Epub 2008 Sep 17. Am J Physiol Cell Physiol. 2008. PMID: 18799650 Free PMC article.
-
[Interaction between tumor necrosis factor-alpha and the smooth muscle cells of the airway: implication in the physiopathology of asthma].Rev Mal Respir. 1996 Dec;13(6):539-46. Rev Mal Respir. 1996. PMID: 9036498 Review. French.
-
Mechanisms underlying the pathogenesis of hyper-contractility of bronchial smooth muscle in allergic asthma.J Smooth Muscle Res. 2017;53(0):37-47. doi: 10.1540/jsmr.53.37. J Smooth Muscle Res. 2017. PMID: 28484126 Free PMC article. Review.
Cited by
-
Low-level laser therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi smooth muscle exposed to tumor necrosis factor-alpha.Lasers Med Sci. 2010 Sep;25(5):661-8. doi: 10.1007/s10103-010-0766-0. Lasers Med Sci. 2010. PMID: 20393772
-
Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial.Lasers Med Sci. 2013 May;28(3):743-53. doi: 10.1007/s10103-012-1129-9. Epub 2012 Jun 21. Lasers Med Sci. 2013. PMID: 22718472 Clinical Trial.
-
Suppressive effect of low-level laser therapy on tracheal hyperresponsiveness and lung inflammation in rat subjected to intestinal ischemia and reperfusion.Lasers Med Sci. 2013 Feb;28(2):551-64. doi: 10.1007/s10103-012-1088-1. Epub 2012 May 5. Lasers Med Sci. 2013. PMID: 22562449
-
Low-level laser therapy (LLLT) acts as cAMP-elevating agent in acute respiratory distress syndrome.Lasers Med Sci. 2011 May;26(3):389-400. doi: 10.1007/s10103-010-0874-x. Epub 2010 Dec 24. Lasers Med Sci. 2011. PMID: 21184127
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous